phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Today marks the beginning of Lesbian, Gay, Bisexual, and Transgender (LGBT) Pride Month and we are proud to join with our member companies in celebrating our support for the LGBT community. We recognize that inclusion and diversity fuels collaboration, trust to make the next leap into biomedical research and fosters an openness to tackling old problems with new ideas.

For the biopharmaceutical industry employees and the patients we seek to help, consideration of each person’s unique contributions fuel the work we do day in and day out.

Below are just some of the initiatives being led by our members to celebrate and advance diversity in biopharmaceutical science:

  • Astellas has created an employee resource group called Together As One (TAO). TAO’s mission is to foster an inclusive and supportive work environment that allows members of Astellas’ LGBTQA community to be their whole selves at work, embodying the spirit of One Astellas.
  • Biogen’s original “Out at Work” campaign encourages its employees to be out and open in the workplace to foster collaboration, communication and career growth. Biogen’s view of diversity and inclusion expands to their patients, researchers, medical teams and supply chain. 
  • Eli Lilly and Company’s corporate and Lilly Field PRIDE created a reverse mentoring program that matches senior leaders with LGBT employees as mentors. This helps educate the leaders about LGBT issues in the workplace.
  • Pfizer established a Colleague Resource Group to help drive the company’s mission and values to position Pfizer among the world’s leading companies for LGBT equality and inclusion. Pfizer also supports LGBT teens and senior citizens through programs like a youth mentoring program with Harvey Milk High School, a NYC public school, and through Pfizer’s healthy aging campaign—Get Old—in partnership with SAGE to support the health care challenges faced by aging LGBT people.

And in honor of Pride Month, PhRMA is a proud sponsor of the DC Front Runners Pride Run on June 9th benefiting the Team DC Student-Athlete Scholarship and SMYAL (Supporting and Mentoring Youth Advocates and Leaders). 

PhRMA and our member companies are proud to celebrate our LGBT colleagues and patients and their important contributions to the drug development process.

Andrew Powaleny

Andrew Powaleny is the Deputy Vice President of Public Affairs at PhRMA, where he leads communications on scientific, regulatory and intellectual property issues, highlighting the biopharmaceutical industry’s efforts in developing innovative medicines and vaccines while promoting an environment that encourages necessary risk-taking. For five years starting in 2019, he launched and led PhRMA’s grassroots initiative, Voters for Cures, bringing patients and caregivers together to advocate for access to medicine and biopharmaceutical innovation. He also co-founded and co-chaired PRIDE Umbrella, a resource group for LGBTQ+ individuals. Prior to joining PhRMA in 2015, Andrew worked as a communications consultant in Washington, D.C., and as Deputy Press Secretary for the U.S. House Committee on Energy and Commerce under Chairman Fred Upton. He holds a degree in public policy and government from Eastern Connecticut State University, with a minor in music. Outside of work, Andrew enjoys exercise, musical theater and mentoring college students through The Fund for American Studies alumni association.

Andrew Powaleny

Author Twitter

Author LinkedIn

Staffing up: Building the future biopharma workforce to keep America in the lead

June 29, 2026

Nearly 80 researchers advocate on Capitol Hill

June 11, 2026

Congratulations to our 2026 Working for Cures Employee Champions

January 29, 2026

Manufacturing U.S. jobs and breakthroughs

October 6, 2025

Historic biopharmaceutical investments: A prescription for America’s future

September 29, 2025

Bringing to life the full story of biopharmaceutical innovation and investments

July 22, 2025

From sound to science: How IP powers innovation in music and hearing

April 25, 2025

Recognizing the value of disease prevention with Dr. Len Friedland from GSK

December 12, 2024

Congratulations to our 2024 Working for Cures Employee Champions

December 11, 2024

The importance of partnership: A conversation with Takeda

October 10, 2024

New research: American biopharmaceutical investment in R&D drives transformational innovation

September 16, 2024

The future of oncology R&D lies in policymakers’ hands

July 8, 2024

More than 60 researchers advocate on Capitol Hill

July 1, 2024

Alzheimer's & Brain Awareness Month: A conversation with Biogen

June 27, 2024

Alzheimer's & Brain Awareness Month: A conversation with Eisai

June 24, 2024

Alzheimer's & Brain Awareness Month: A conversation with Eli Lilly and Company

June 20, 2024

Powering the next generation of therapies: A conversation with Astellas US President Mark Reisenauer

January 30, 2024

Congratulations to our 2023 Working for Cures Employee Champions

December 6, 2023

Watch: Putting patients front and center for World AIDS Day

November 30, 2023

New Report: 1,600 cancer treatments and vaccines in clinical development

November 9, 2023

Watch: New video series spotlights advances in biopharmaceutical science

August 24, 2023

New report shows high-impact R&D happens after cancer medicines are first approved

July 10, 2023

More than 60 researchers ask Congress to support innovation

June 26, 2023

Biopharmaceutical science powered by PRIDE

June 16, 2023

Addressing Mental Health: A conversation with Barry Greene, CEO of Sage Therapeutics

May 30, 2023

World IP Day 2023: Celebrating women leaders in innovation

April 26, 2023

What we’ve learned from three years of fighting COVID-19

March 20, 2023

WTAS: Inflation Reduction Act already impacting R&D decisions

January 17, 2023

Sparking conversations — and careers — at the 2nd annual Pathways to Success Summit

December 8, 2022

Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

December 1, 2022

Congratulations to our 2022 Working for Cures Employee Champions

November 10, 2022

Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus

October 13, 2022

An open letter to Congress: Stand with patients and future cures

August 4, 2022

PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021

July 18, 2022

Biopharmaceutical researchers to discuss the value of R&D with Congress

June 9, 2022

A conversation with Barry Greene, CEO of Sage Therapeutics

May 4, 2022

Stephanie Dyson of BMS on reducing health disparities

April 27, 2022

Biopharmaceutical industry drives economic growth in all 50 states

March 14, 2022

Guest post: Joining forces to combat the COVID-19 mental health crisis

February 17, 2022

Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry

September 28, 2021

Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda

September 27, 2021

Industry leaders discuss the impact of the drug pricing debate

September 23, 2021

PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020

July 22, 2021

Watch: Building trust and enhancing clinical trial diversity

June 24, 2021

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US

June 23, 2021

Researchers to shine light on biopharmaceutical R&D with policymakers

June 15, 2021

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

March 5, 2021

Coming together to fight COVID-19: A conversation with Paul Perreault, CEO and Managing Director of CSL

February 24, 2021

Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

January 28, 2021

Report highlights biopharmaceutical industry’s commitment to D&I

December 17, 2020

Guest Post: Bringing our best to the fight against COVID-19

December 3, 2020

An unprecedented year and the road ahead: A conversation with Giovanni Caforio, PhRMA Chairman and CEO of Bristol Myers Squibb

November 18, 2020

Coming together to fight COVID-19: A conversation with Peter Anastasiou, Executive Vice President of Lundbeck

October 28, 2020

New Report: The biopharmaceutical industry’s sustained commitment to inspiring and advancing tomorrow’s STEM workforce

October 12, 2020

Coming together to fight COVID-19: A conversation with Alexander Hardy, CEO of Genentech

October 1, 2020

Leading researchers to spotlight the critical role of biopharmaceutical R&D

October 1, 2020

Coming together to fight COVID-19: A conversation with Ramona Sequeira, President of Takeda Pharmaceuticals U.S.A

September 23, 2020

Coming together to fight COVID-19: A conversation with Albert Bourla, Chairman & CEO of Pfizer, Inc.

September 17, 2020

Guest Post: How proactivity and planning helped Novartis ensure a stable supply of medicines during COVID-19

September 16, 2020

PhRMA member companies invested $83 billion in research and development last year

September 10, 2020

Coming together to fight COVID-19: A conversation with Paul Hudson, CEO of Sanofi

September 2, 2020

Three ways the pharmaceutical industry can positively impact health equity

September 1, 2020

ICYMI: The latest as America’s biopharmaceutical companies work to beat COVID-19

August 4, 2020

New report explores setbacks that bring future cancer success stories

July 16, 2020

In combating COVID-19, science is how we get back to normal

June 24, 2020

Guest Post: Takeda seeks ‘new normal’ for cancer research during the COVID-19 pandemic

June 24, 2020

Guest Post: What will we learn from COVID-19?

May 27, 2020

Lilly, Merck and Pfizer empower team members to volunteer on COVID-19 frontlines

April 15, 2020

To the millions affected by COVID-19

April 9, 2020

Merck’s Dr. Julie Gerberding on the threat of antimicrobial resistance and COVID-19

April 6, 2020

The biopharmaceutical industry’s unique role in responding to COVID-19

April 2, 2020

ICYMI: America’s biopharmaceutical companies are working 'around the clock' to beat coronavirus

April 1, 2020

COVID-19 Response: Supporting the frontline

March 30, 2020

Guest post: Looking out for the invisibly vulnerable in the time of COVID-19

March 26, 2020

America’s biopharmaceutical companies are working around the clock to beat coronavirus

March 20, 2020

Guest post: Takeda’s efforts to address COVID-19

March 19, 2020

ICYMI: America’s biopharmaceutical companies are taking on COVID-19

March 16, 2020

ICYMI: Continued biopharmaceutical action on COVID-19

March 6, 2020

Working together to combat coronavirus

February 6, 2020

The journey to better health care requires a holistic view

September 18, 2017

Helping those affected by the 2017 hurricane season

August 31, 2017

Guest Post: The importance of a modern FDA in drug discovery

March 22, 2017

Exploring the new era of medicine

February 21, 2017

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?

February 15, 2017

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

February 14, 2017

Celebrating PRIDE in biopharmaceutical science

PhRMA Member Company

Celebrating PRIDE in biopharmaceutical science

June 1, 2017

Celebrating PRIDE in biopharmaceutical science

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list